Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial
Published inGastroentérologie clinique et biologique, vol. 33, no. 1 Pt 1, p. 31-40
Publication date2009
Abstract
Keywords
- Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
- Child
- Crohn Disease/*drug therapy
- Double-Blind Method
- Female
- Humans
- Male
- Mesalamine/*therapeutic use
- Recurrence/prevention & control
- Treatment Outcome
Affiliation entities
Citation (ISO format)
CEZARD, J-P et al. Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn’s disease: a multicenter, double-blind, randomized, placebo-controlled trial. In: Gastroentérologie clinique et biologique, 2009, vol. 33, n° 1 Pt 1, p. 31–40. doi: 10.1016/j.gcb.2008.07.007
Main files (1)
Article
Identifiers
- PID : unige:19732
- DOI : 10.1016/j.gcb.2008.07.007
- PMID : 19118966
Additional URL for this publicationhttp://pdn.sciencedirect.com/science?_ob=MiamiImageURL&_cid=276860&_user=9565874&_pii=S039983200800479X&_check=y&_origin=article&_zone=toolbar&_coverDate=31-Jan-2009&view=c&originContentFamily=serial&wchp=dGLbVlB-zSkzS&md5=e63d0e8a2c2f21969a59351e0e84b0c6/1-s2.0-S039983200800479X-main.pdf
Journal ISSN0399-8320